ELLIOT J MD MBA SUSSMAN, a director at $UHS, sold 965 shares of the company on 10-29-2025 for an estimated $217,798. We received data on the trade from a recent SEC filing. This was a sale of approximately 13.6% of their shares of this class of stock. Following this trade, they now own 6,113 shares of this class of $UHS stock.
$UHS Insider Trading Activity
$UHS insiders have traded $UHS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $UHS stock by insiders over the last 6 months:
- ELLIOT J MD MBA SUSSMAN sold 965 shares for an estimated $217,798
- MARIA RUDERMAN SINGER sold 1,097 shares for an estimated $210,053
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UHS Hedge Fund Activity
We have seen 316 institutional investors add shares of $UHS stock to their portfolio, and 309 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 497,893 shares (-56.1%) from their portfolio in Q2 2025, for an estimated $90,193,316
- BLACKROCK, INC. removed 472,008 shares (-8.6%) from their portfolio in Q2 2025, for an estimated $85,504,249
- SQUAREPOINT OPS LLC removed 379,304 shares (-87.2%) from their portfolio in Q2 2025, for an estimated $68,710,919
- MARSHALL WACE, LLP removed 325,481 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $58,960,883
- PRICE T ROWE ASSOCIATES INC /MD/ added 324,550 shares (+386.3%) to their portfolio in Q2 2025, for an estimated $58,792,232
- FREESTONE GROVE PARTNERS LP added 252,750 shares (+310.5%) to their portfolio in Q2 2025, for an estimated $45,785,662
- BANK OF AMERICA CORP /DE/ removed 229,537 shares (-50.9%) from their portfolio in Q2 2025, for an estimated $41,580,627
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$UHS Analyst Ratings
Wall Street analysts have issued reports on $UHS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 10/29/2025
- UBS issued a "Buy" rating on 10/29/2025
- Barclays issued a "Overweight" rating on 10/28/2025
- Wells Fargo issued a "Overweight" rating on 08/14/2025
To track analyst ratings and price targets for $UHS, check out Quiver Quantitative's $UHS forecast page.
$UHS Price Targets
Multiple analysts have issued price targets for $UHS recently. We have seen 10 analysts offer price targets for $UHS in the last 6 months, with a median target of $240.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $231.0 on 10/30/2025
- Jason Cassorla from Guggenheim set a target price of $253.0 on 10/29/2025
- A.J. Rice from UBS set a target price of $302.0 on 10/29/2025
- Sarah James from Cantor Fitzgerald set a target price of $250.0 on 10/29/2025
- Andrew Mok from Barclays set a target price of $263.0 on 10/28/2025
- Scott Fidel from Goldman Sachs set a target price of $219.0 on 10/14/2025
- Stephen Baxter from Wells Fargo set a target price of $249.0 on 10/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
